Product Name | MF | CAS | Details |
---|
4-Fluoro-2-(trifluoromethyl)benzoic acid | C8H4F4O2 | 141179-72-8 | Details |
6-Bromo-1H-indazol-5-ol | C7H5BrN2O | 1206800-18-1 | Details |
(2S,4S)-tert-Butyl 4-hydroxy-2-methylpyrrolidine-1-carboxylate | C10H19NO3 | 477293-60-0 | Details |
(5,6,7,8-tetrahydronaphthalen-2-yl)methanamine | C11H15N | 15402-69-4 | Details |
Methyl 4-(3-(difluoromethoxy)phenyl)-2,4-dioxobutanoate | C12H10F2O5 | 832741-03-4 | Details |
2-Hydroxy-1H-indole-3-carbonitrile | C9H6N2O | 1146290-35-8 | Details |
5-Isothiocyanatoquinoline | C10H6N2S | 1001183-84-1 | Details |
2-[2-(2-Chlorophenyl)-1,3-thiazol-4-yl]ethan-1-amine | C11H11ClN2S | 938377-76-5 | Details |
CD157 antibody | Details |
5-Chloro-1-[3-(1H-imidazol-1-yl)propyl]-1H-1,3-benzodiazol-2-amine | C13H14ClN5 | 1154368-05-4 | Details |
Fkbp12 protac rc32 | C75H107N7O20 | 2375555-66-9 | Details |
Carbazomycin B | 75139-38-7 | Details |
Benzo[1,3]dioxol-5-ylmethyl-(2-methoxy-ethyl)-amine | C11H15NO3 | 117986-59-1 | Details |
(4,4-Difluoropiperidine)-1-sulfonyl chloride | C5H8ClF2NO2S | 1224929-81-0 | Details |
RGS2 antibody | Details |
2-(1-Hydroxyethyl)-1,3-thiazole-5-carbaldehyde | C6H7NO2S | 1803605-24-4 | Details |
6-Chloro-3,4-dihydro-1,2,3-benzotriazin-4-one | C7H4ClN3O | 37429-97-3 | Details |
Methyl 3-amino-3-deoxy-α-D-mannopyranoside hydrochloride | C7H16ClNO5 | 14133-35-8 | Details |
1-Phenyl-1,2,4-triazolidine-3,5-dione | C8H7N3O2 | 6942-46-7 | Details |
Vitexin | C21H20O10 | 3681-93-4 | Details |
H-MVTGVASALSSR-OH | Details |
(1R,2S)-Cis-2-hydroxycyclohexane-carboxylic acid ethylester | C9H16O3 | 61586-78-5 | Details |
5-Chloro[1,2,4]triazolo[1,5-a]pyrazin-2-amine | C5H4ClN5 | 1454653-85-0 | Details |
(6-Bromo-5-fluoropyridin-2-yl)methanol | C6H5BrFNO | 1227599-50-9 | Details |
Imidazo[1,2-a]pyridin-5-amine hydrochloride | C7H8ClN3 | 204927-15-1 | Details |
2,5-Didodecoxyterephthalaldehyde | C32H54O4 | 123415-45-2 | Details |
2'-Deoxycytidine-5'-diphosphate trisodium salt hydrate | C9H18N3NaO11P2 | 151151-32-5 | Details |
[1,2,4]Triazolo[1,5-a]pyrimidin-2-ylamine | C5H5N5 | 13223-53-5 | Details |
Cdk1 Mouse Ab (FITC) | Details |
MK-1064 | C24H20ClN5O3 | 1207253-08-4 | Details |
4,6-Diamino-2-(b-D-ribofuranosyl)-2H-pyrazolo[3,4-d]pyrimidine | C10H14N6O4 | 124137-35-5 | Details |
4-Oxo-1H,4H,5H-pyrazolo[3,4-d]pyrimidine-3-carboxylic acid | C6H4N4O3 | 864872-01-5 | Details |
IgG protein (Human) (Fab'2) | Details |
DYNC1LI1 antibody | Details |
1-(1,3-Benzodioxol-5-yl)ethanamine | C9H11NO2 | 121734-64-3 | Details |
6-(2,3-Dimethylphenoxy)-2-methyl-3-nitropyridine | 2375271-13-7 | Details |
1,2,3,4-Tetra-O-benzyl-6-O-tert-butyldimethylsilyl-a-D-mannopyranose | C40H50O6Si | Details |
(4-Chloro-3-nitrophenyl)acetic acid | C8H6ClNO4 | 37777-68-7 | Details |
PCSK4 Blocking Peptide | Details |
MLL4 antibody | Details |
CHCHD5 antibody | Details |
5-[(4-Methylphenyl)amino]-1,3,4-thiadiazole-2-thiol | C9H9N3S2 | 14731-25-0 | Details |
MEK162 | C17H15BrF2N4O3 | 606143-89-9 | Details |
2,5-Dihydroxyterephthalaldehyde | C8H6O4 | 1951-36-6 | Details |
3-Methoxy-1-methyl-1h-pyrazole-4-carboxylic acid | C6H8N2O3 | 113100-56-4 | Details |
1,4-dioxa-9-azadispiro[4.2.4??.2?μ]tetradecan-10-one | C11H17NO3 | 686723-63-7 | Details |
Anemarrhenasaponin III | C39H64O14 | 163047-23-2 | Details |
N6-(tert-Butylphenoxyacetyl)-2'-O-methyl-5'-O-DMT-adenosine 3'-CE phosphoramidite | Details |
3-(Chloromethyl)-5-(pyrrolidin-1-yl)-1,2,4-oxadiazole | C7H10ClN3O | 1393575-94-4 | Details |
6-Hydroxy-5-methoxy-1-indanone | C10H10O3 | 90843-62-2 | Details |
TD-198946 | C27H22N4O3S | 364762-86-7 | Details |
4-Cyclopropyl-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol | C10H10N4S | 854137-75-0 | Details |
3-(Bromomethyl)-2-fluorobenzonitrile | C8H5BrFN | 1246527-18-3 | Details |
OPN5 antibody | Details |
7-Hydroxy-2,3,4,5-tetrahydro-1H-1-benzazepin-2-one | C10H11NO2 | 22245-90-5 | Details |
2-(3-Piperidinyl)-1,3-benzothiazole hydrochloride | C12H15ClN2S | 51785-16-1 | Details |
beta-Casein (90-96) | C43H64N10O12 | 83471-49-2 | Details |
N-(4-(((4-((isopropyl)phenylamino)phenyl)amino)sulfonyl)phenyl)ethanamide | C23H25N3O3S | 1023532-90-2 | Details |
4-(3-Amino-1,2,4-triazin-5-yl)benzonitrile | C10H7N5 | 1094296-78-2 | Details |
3-(Furan-2-yl)-1-(3-methylphenyl)-1H-pyrazol-5-amine | C14H13N3O | 956515-98-3 | Details |
3-Methyl-5-sulfamoylthiophene-2-carboxylic acid | C6H7NO4S2 | 1096876-87-7 | Details |
Ela1 Blocking Peptide | Details |
5-Taurinomethyl-2-thiouridine | C12H19N3O8S2 | 497258-54-5 | Details |
2-Bromo-2,2-difluoroethyl trifluoromethanesulfonate | C3H2BrF5O3S | 1989672-35-6 | Details |
tert-Butyl N-(4-isocyanobutyl)carbamate | C10H18N2O2 | 353505-05-2 | Details |
LHX5 antibody | Details |
(4-Chloro-3-methyl-phenyl)-hydrazine | C7H9ClN2 | 62646-06-4 | Details |
Pig CRP Reference Serum | Details |
ANGPTL5 Blocking Peptide | Details |
1-[(tert-Butoxy)carbonyl]-3-[(prop-2-en-1-yloxy)methyl]pyrrolidine-3-carboxylic acid | C14H23NO5 | 2149185-87-3 | Details |
2-Fluoro-5-(morpholine-4-sulfonyl)aniline | C10H13FN2O3S | 1017390-45-2 | Details |
2-[(Thiophen-2-yl)methoxy]benzoic acid | C12H10O3S | 67443-52-1 | Details |
2-Methoxyphenazin-1-amine | C13H11N3O | 3224-52-0 | Details |
4-Amino-6-methyl-3-sulfanyl-4,5-dihydro-1,2,4-triazin-5-one hydrochloride | 2137786-24-2 | Details |
LCBiot-YGGFLRRI-OH | Details |
tert-Butyl N-({1-oxaspiro[2.3]hexan-5-yl}methyl)carbamate | C11H19NO3 | 1154759-52-0 | Details |
tert-Butyl N-(5-hydroxy-2-nitrophenyl)carbamate | C11H14N2O5 | 335352-07-3 | Details |
KHDC1L protein (His tag) | Details |
B7H4 antibody (PE) | Details |
FGD3 antibody | Details |
3-(Piperidin-4-yl)butanoic acid | C9H17NO2 | 103039-96-9 | Details |
RACK1A antibody | Details |
2-Phenyl-3-azabicyclo[3.2.1]octane | C13H17N | 100608-29-5 | Details |
2,2,2-Trifluoro-1-(3-nitrophenyl)ethan-1-amine | C8H7F3N2O2 | 1248504-66-6 | Details |
4-Hydroxy-1-benzofuran-3-carboxylic acid | C9H6O4 | 112678-09-8 | Details |
1-Methyl-2-(4-nitrophenyl)-1H-imidazole | C10H9N3O2 | 334952-04-4 | Details |
(S,S)-Valifenalate | C19H27ClN2O5 | 283159-94-4 | Details |
Catenin alpha 1/2 antibody | Details |
2-{[3-(Aminomethyl)oxolan-3-yl]oxy}ethan-1-ol | C7H15NO3 | 1694446-17-7 | Details |
Cyclobuxine D | C25H42N2O | 2241-90-9 | Details |
1-(3-Cyclobutyl-1-methyl-1H-pyrazol-5-yl)ethan-1-one | C10H14N2O | 1893162-23-6 | Details |
2-{[(tert-Butoxy)carbonyl]amino}-3-(piperidin-1-yl)propanoic acid hydrochloride | C13H25ClN2O4 | 1803562-92-6 | Details |
4-(5-Amino-3-tert-butyl-1H-pyrazol-1-yl)benzonitrile hydrochloride | C14H17ClN4 | 1215333-30-4 | Details |
N-(4-Fluorophenyl)(5-methyl-3-phenylisoxazol-4-yl)formamide | C17H13FN2O2 | 505088-42-6 | Details |
2-{[5-(4-tert-Butylphenyl)-4-phenyl-4H-1,2,4-triazol-3-yl]sulfanyl}acetohydrazide | C20H23N5OS | 893726-22-2 | Details |
[(2-Fluoro-5-methylphenyl)amino]carbonitrile | C8H7FN2 | 1248664-55-2 | Details |
Claudin 17 Blocking Peptide | Details |
(3-Chlorophenyl)(4-methylphenyl)methanamine | C14H14ClN | 701212-45-5 | Details |
4,5-Dimethyl 1H-1,2,3-triazole-4,5-dicarboxylate | C6H7N3O4 | 707-94-8 | Details |
(S)-Famoxadone | C22H18N2O4 | 132584-12-4 | Details |
Product Total: Product Page: | ||||
219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 |